India to centralize testing of 42 veterinary vaccines under regulatory overhaul
Subscribe to enjoy similar stories. NEW DELHI: India plans to centralize testing and quality control of 42 essential veterinary vaccines at a single national laboratory, replacing a fragmented system that allows self-certification and state-level testing, according to two government officials and a document reviewed by Mint.
The move, set in motion by the Drugs Technical Advisory Board (DTAB), will designate the Baghpat-based Chaudhary Charan Singh National Institute of Animal Health (CCSNIAH) as the exclusive apex laboratory for batch release and quality assessment of these biological products. The vaccines span livestock, poultry, and companion animals.
The overhaul aims to standardize testing under Indian Pharmacopoeia (IP) rules that are legally enforceable standards defining a drug’s identity, purity and strength, and create a single point of accountability for safety and efficacy. At present, veterinary vaccine manufacturers often self-certify batches or rely on state and regional laboratories.
Officials said the proposed amendment seeks to end this system. The amendment was issued as a draft notification on 28 January 2026 and will be finalized after a 30-day public consultation period, officials said.
“By vesting batch-release and quality-control functions for this entire basket of 42 vaccines in a single apex institute (CCSNIAH), the government aims to standardize testing as per Indian Pharmacopoeia norms, remove regional inconsistencies, and create a clear accountability point for safety and efficacy," a spokesperson for the Department of Animal Husbandry and Dairying said in an emailed response. “Standardized testing at a national hub ensures that vaccines are not only safe but possess the required potency to
. Read on livemint.com